Table 1 Characteristics of the patients from whom myocardial fragments were taken
From: Remifentanil but not sufentanil induces cardioprotection in human ischemic heart muscle in vitro
Number of patients | 104 (100%) |
Males | 82 (79%) |
Females | 22 (21%) |
Age (years) | 64,8 ± 9.7 |
Left ventricle ejection fraction (%) | 50,7 ± 8,5 |
Diabetes | 23 (22%) |
Diabetes on insulin treatment | 10 (9%) |
Beta-blockers | 97 (93%) |
Calcium channel blockers | 23 (22%) |
ACE inhibitors | 67 (64%) |
Angiotensin receptor blockers | 2 (2%) |
Aspirin | 89 (86%) |
Statins | 89 (86%) |